Revised simulation model does not predict rebound in gonorrhoea prevalence where core groups are treated in the presence of antimicrobial resistance: Figure 1
Trecker, Molly A, Hogan, Daniel J, Waldner, Cheryl L, Dillon, Jo-Anne R, Osgood, Nathaniel DVolume:
91
Language:
english
Journal:
Sexually Transmitted Infections
DOI:
10.1136/sextrans-2014-051792
Date:
June, 2015
File:
PDF, 659 KB
english, 2015